Daijiworld Media Network - New Delhi New Delhi, May 2: A class of diabetes drugs known as SGLT2 inhibitors may significantly reduce the risk of organ rejection in patients undergoing heart transplantation, according to a recent meta-analysis. The study, based on eight research papers involving 2,755 participants, exa.....